DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Calicheamicin
Calicheamicin
C-1027, a Radiomimetic Enediyne Anticancer Drug, Preferentially Targets Hypoxic Cells
Enediynes, Enyneallenes, Their Reactions, and Beyond
Inotuzumab Ozogamicin Is an Investigational Agent and Has Not Been Approved for Marketing by Any Regulatory Agency at This Time
Antibody-Drug Conjugates of Calicheamicin Derivative: Gemtuzumab Ozogamicin and Inotuzumab Ozogamicin
The Novel Calicheamicin-Conjugated CD22 Antibody Inotuzumab Ozogamicin (CMC-544) Effectively Kills Primary Pediatric Acute Lymphoblastic Leukemia Cells
Total Synthesis of Calicheamicin Type Enediyne Natural Products
Functional and Structural Characterization of the Proteins from Early Steps of Calicheamicin Biosynthesis
Antibody–Drug Conjugates for Cancer Therapy
The Chemistry of Nine-Membered Enediyne Natural Products
Developments and Challenges for Mab-Based Therapeutics
Transcriptional Effects of the Potent Enediyne Anti-Cancer Agent
Population Pharmacokinetics of Inotuzumab Ozogamicin in Relapsed/ Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma
Assessment of Clinical Immunogenicity of Inotuzumab Ozogamicin In
Enediyne Natural Products: Biosynthesis and Prospect Towards Engineering Novel Antitumor Agents
Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
Kedarcidin Chromophore: an Enediyne That Cleaves DNA in a Sequence-Specific Manner N
Mylotarg, INN-Gemtuzumab Ozogamicin
Kedarcidin Chromophore: an Enediyne That Cleaves DNA in a Sequence-Specific Manner N
Top View
A New Class of Antibody-Drug Conjugates with Potent DNA Alkylating
MYLOTARG (Gemtuzumab Ozogamicin)
Single Chemical Modifications of the C-1027 Enediyne Core, A
Immunotoxins and Anticancer Drug Conjugate Assemblies: the Role of the Linkage Between Components
Synthetic Approaches to Fluorinated Ten-Membered Enediyne
Complete Set of Glycosyltransferase Structures in the Calicheamicin Biosynthetic Pathway Reveals the Origin of Regiospecificity
The Reactivity of Calicheamicin [Gamma]1I in the Minor Groove Of
Review Chemistry and Biology of Natural and Designed Enediynes K
Selective Proteolytic Activity of the Antitumor Agent Kedarcidin N
Antibody-Drug Conjugates: the New Frontier of Chemotherapy
E Speramicin- a Cytotoxic Antitumor Antibiotic
Salvage Chemoimmunotherapy with Inotuzumab Ozogamicin Combined
Clinical Pharmacology Biopharmaceutics Review(S)
Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria
Polyketide Synthase Chemistry Does Not Direct Biosynthetic Divergence Between 9- and 10-Membered Enediynes
761040Orig1s000
Crystal Structure of O-Methyltransferase Calo6 from the Calicheamicin Biosynthetic Pathway: a Case of Challenging Structure Determination at Low Resolution Oleg V
CMC-544 (Inotuzumab Ozogamicin): a CD22-Targeted Immunoconjugate
DRUG NAME: Inotuzumab Ozogamicin
Antibody–Drug Conjugates: a Comprehensive Review Puregmaa Khongorzul1, Cai Jia Ling1, Farhan Ullah Khan2, Awais Ullah Ihsan3, and Juan Zhang1
Inotuzumab Ozogamicin in Clinical Development for Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma Amandeep Aujla1, Ravijot Aujla2 and Delong Liu1,3*